{"id":53269,"date":"2023-01-25T11:02:11","date_gmt":"2023-01-25T10:02:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/"},"modified":"2023-01-25T11:02:11","modified_gmt":"2023-01-25T10:02:11","slug":"blackford-and-brainomix-announce-ai-partnership-for-stroke-care","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/","title":{"rendered":"Blackford and Brainomix Announce AI Partnership for Stroke Care"},"content":{"rendered":"
\n

\nStrategic partnership increases access to advanced AI-assisted stroke care<\/i>\n<\/p>\n

EDINBURGH, Scotland–(BUSINESS WIRE)–#AI<\/a>–Blackford, the pioneering strategic imaging AI platform and solutions provider, and Brainomix, the AI-powered medtech solutions company, have announced a strategic partnership to bring Brainomix\u2019s comprehensive e-Stroke<\/b> solution to the Blackford Platform, making advanced stroke care available to more institutions around the world.\n<\/p>\n

<\/a><\/p>\n

\nAccording to the World Stroke Organization, there are over 12.2 million new strokes each year. In more rural areas, access to advanced imaging may be limited, which can have a negative impact on stroke diagnosis and treatment. Brainomix\u2019s e-Stroke<\/b> AI tools can generate real-time interpretation of more widely available non-contrast CT exams, expanding access to life-saving stroke treatments.\n<\/p>\n

\n“Timely diagnosis and treatment of stroke should not be limited to urban areas and comprehensive stroke centers,\u201d said Blackford Founder and CEO Ben Panter. \u201cAdding Brainomix\u2019s AI-powered e-Stroke<\/b> to the Blackford Platform allows more institutions around the world to accelerate transfer and treatment times and expand access to critical endovascular therapy for their patients.\u201d\n<\/p>\n

\nBrainomix\u2019s AI-powered e-Stroke<\/b> tools can utilize images from non-contrast or contrast enhanced CT exams to provide physicians fast, effective, and accurate analysis of images that expedite treatment decisions. Combined with the e-Stroke Mobile<\/b> app, physicians can quickly and securely access, review, and share patient images and data to optimize workflow and facilitate faster transfer and treatment decisions.\n<\/p>\n

\n\u201cWe are very excited to launch this partnership with Blackford \u2013 a company that has firmly established itself as a leading provider of tailored best-in-class medical imaging and AI-powered solutions that deliver clinical value, with an extensive customer base and a highly regarded focus on technical excellence,\u201d said Dr Michalis Papadakis, CEO & co-founder at Brainomix. \u201cWith our e-Stroke platform, we believe that we have the opportunity to work together to provide physicians with the most comprehensive stroke AI imaging solution, shown to optimize networks and ultimately improve patient outcomes.\u201d\n<\/p>\n

\nAbout Brainomix:<\/b>\n<\/p>\n

\nBrainomix specializes in the creation of AI-powered software solutions to enable precision medicine for better treatment decisions in stroke, lung fibrosis, and cancer. With origins as a spin-out from the University of Oxford, Brainomix is an expanding commercial-stage company that has innovated award-winning imaging biomarkers and software solutions that are used in more than 30 countries worldwide. Its first product, the e-Stroke platform, provides clinicians with the most comprehensive stroke imaging solution, driving faster treatment times, and improving functional independence for patients.\n<\/p>\n

\nTo learn more about Brainomix and its technology visit www.brainomix.com<\/a>, and follow us on Twitter<\/a>, LinkedIn<\/a> and Facebook<\/a>.\n<\/p>\n

\nAbout Blackford:<\/b>\n<\/p>\n

\nBlackford provides tailored tools and services to unlock the value of imaging AI, drive efficiencies, and improve patient outcomes. For over a decade, Blackford has worked in partnership with leading hospitals and ground-breaking technology providers to integrate best-fit AI into clinical workflows to realize ongoing value. Partnering with Blackford provides healthcare organizations access to the widest available portfolio of AI solutions via a single tried-and-tested platform.\n<\/p>\n

\nTo learn more about Blackford\u2019s tailored approach to AI solutions visit www.blackfordanalysis.com<\/a>, and follow us on Twitter<\/a> and LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nBlackford Media Contact:
\n
Nick Cole
\n
nick.cole@blackfordanalysis.com<\/a>
Phone: +44 7812164790\n<\/p>\n

\nBrainomix Media Contact:
\n
Sue Charles
\n
sue@charles-consultants.com<\/a>
Phone: +44 7968726585\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Strategic partnership increases access to advanced AI-assisted stroke care EDINBURGH, Scotland–(BUSINESS WIRE)–#AI–Blackford, the pioneering strategic imaging AI platform and solutions provider, and Brainomix, the AI-powered medtech solutions company, have announced a strategic partnership to bring Brainomix\u2019s comprehensive e-Stroke solution to the Blackford Platform, making advanced stroke care available to more institutions around the world. According … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53269","6":"format-standard","7":"category-industry"},"yoast_head":"\nBlackford and Brainomix Announce AI Partnership for Stroke Care - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blackford and Brainomix Announce AI Partnership for Stroke Care - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Strategic partnership increases access to advanced AI-assisted stroke care EDINBURGH, Scotland–(BUSINESS WIRE)–#AI–Blackford, the pioneering strategic imaging AI platform and solutions provider, and Brainomix, the AI-powered medtech solutions company, have announced a strategic partnership to bring Brainomix\u2019s comprehensive e-Stroke solution to the Blackford Platform, making advanced stroke care available to more institutions around the world. According ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-25T10:02:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230125005059\/en\/1289420\/21\/BlackfordAnalysisLogo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Blackford and Brainomix Announce AI Partnership for Stroke Care\",\"datePublished\":\"2023-01-25T10:02:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/\"},\"wordCount\":540,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005059\\\/en\\\/1289420\\\/21\\\/BlackfordAnalysisLogo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/\",\"name\":\"Blackford and Brainomix Announce AI Partnership for Stroke Care - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005059\\\/en\\\/1289420\\\/21\\\/BlackfordAnalysisLogo.jpg\",\"datePublished\":\"2023-01-25T10:02:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005059\\\/en\\\/1289420\\\/21\\\/BlackfordAnalysisLogo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005059\\\/en\\\/1289420\\\/21\\\/BlackfordAnalysisLogo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blackford and Brainomix Announce AI Partnership for Stroke Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Blackford and Brainomix Announce AI Partnership for Stroke Care - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/","og_locale":"en_US","og_type":"article","og_title":"Blackford and Brainomix Announce AI Partnership for Stroke Care - Pharma Trend","og_description":"Strategic partnership increases access to advanced AI-assisted stroke care EDINBURGH, Scotland–(BUSINESS WIRE)–#AI–Blackford, the pioneering strategic imaging AI platform and solutions provider, and Brainomix, the AI-powered medtech solutions company, have announced a strategic partnership to bring Brainomix\u2019s comprehensive e-Stroke solution to the Blackford Platform, making advanced stroke care available to more institutions around the world. According ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-25T10:02:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230125005059\/en\/1289420\/21\/BlackfordAnalysisLogo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Blackford and Brainomix Announce AI Partnership for Stroke Care","datePublished":"2023-01-25T10:02:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/"},"wordCount":540,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230125005059\/en\/1289420\/21\/BlackfordAnalysisLogo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/","url":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/","name":"Blackford and Brainomix Announce AI Partnership for Stroke Care - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230125005059\/en\/1289420\/21\/BlackfordAnalysisLogo.jpg","datePublished":"2023-01-25T10:02:11+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230125005059\/en\/1289420\/21\/BlackfordAnalysisLogo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230125005059\/en\/1289420\/21\/BlackfordAnalysisLogo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/blackford-and-brainomix-announce-ai-partnership-for-stroke-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Blackford and Brainomix Announce AI Partnership for Stroke Care"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53269"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53269\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}